Results
1
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
1 companies
PharmaEssentia
Market Cap: NT$598.9b
A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.
6446
NT$1,495.00
7D
20.6%
1Y
265.1%